Correlation Between AN2 Therapeutics and Werewolf Therapeutics
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Werewolf Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Werewolf Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Werewolf Therapeutics, you can compare the effects of market volatilities on AN2 Therapeutics and Werewolf Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Werewolf Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Werewolf Therapeutics.
Diversification Opportunities for AN2 Therapeutics and Werewolf Therapeutics
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between AN2 and Werewolf is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Werewolf Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Werewolf Therapeutics and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Werewolf Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Werewolf Therapeutics has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Werewolf Therapeutics go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Werewolf Therapeutics
Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 1.13 times more return on investment than Werewolf Therapeutics. However, AN2 Therapeutics is 1.13 times more volatile than Werewolf Therapeutics. It trades about 0.21 of its potential returns per unit of risk. Werewolf Therapeutics is currently generating about -0.26 per unit of risk. If you would invest 109.00 in AN2 Therapeutics on August 31, 2024 and sell it today you would earn a total of 28.00 from holding AN2 Therapeutics or generate 25.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
AN2 Therapeutics vs. Werewolf Therapeutics
Performance |
| Timeline |
| AN2 Therapeutics |
| Werewolf Therapeutics |
AN2 Therapeutics and Werewolf Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AN2 Therapeutics and Werewolf Therapeutics
The main advantage of trading using opposite AN2 Therapeutics and Werewolf Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Werewolf Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Werewolf Therapeutics will offset losses from the drop in Werewolf Therapeutics' long position.| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
| Werewolf Therapeutics vs. Monte Rosa Therapeutics | Werewolf Therapeutics vs. Design Therapeutics | Werewolf Therapeutics vs. Ikena Oncology | Werewolf Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |